- Home
- DLHC vs CNTB Comparison
DLHC vs CNTB Comparison
Compare DLHC & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- CNTB
- Stock Information
- Founded
- DLHC 1969
- CNTB 2012
- Country
- DLHC United States
- CNTB United States
- Employees
- DLHC N/A
- CNTB N/A
- Industry
- DLHC Business Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- DLHC Consumer Discretionary
- CNTB Health Care
- Exchange
- DLHC Nasdaq
- CNTB Nasdaq
- Market Cap
- DLHC 80.0M
- CNTB 90.3M
- IPO Year
- DLHC N/A
- CNTB 2021
- Fundamental
- Price
- DLHC $5.66
- CNTB N/A
- Analyst Decision
- DLHC
- CNTB Strong Buy
- Analyst Count
- DLHC 0
- CNTB 2
- Target Price
- DLHC N/A
- CNTB $7.50
- AVG Volume (30 Days)
- DLHC 16.5K
- CNTB 88.0K
- Earning Date
- DLHC 08-06-2025
- CNTB 11-13-2025
- Dividend Yield
- DLHC N/A
- CNTB N/A
- EPS Growth
- DLHC 80.25
- CNTB N/A
- EPS
- DLHC 0.31
- CNTB N/A
- Revenue
- DLHC $359,723,000.00
- CNTB $1,965,000.00
- Revenue This Year
- DLHC N/A
- CNTB N/A
- Revenue Next Year
- DLHC N/A
- CNTB $453,067.90
- P/E Ratio
- DLHC $18.00
- CNTB N/A
- Revenue Growth
- DLHC N/A
- CNTB N/A
- 52 Week Low
- DLHC $2.72
- CNTB $1.23
- 52 Week High
- DLHC $9.58
- CNTB $2.20
- Technical
- Relative Strength Index (RSI)
- DLHC 48.87
- CNTB 58.99
- Support Level
- DLHC $5.58
- CNTB $1.36
- Resistance Level
- DLHC $5.60
- CNTB $1.88
- Average True Range (ATR)
- DLHC 0.10
- CNTB 0.15
- MACD
- DLHC -0.01
- CNTB 0.04
- Stochastic Oscillator
- DLHC 15.30
- CNTB 99.48
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.